Trials / Completed
CompletedNCT03113448
0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy
0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double- Blind, Crossover, Placebo-Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Thammasat University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To study that 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial
Detailed description
Neuropathy is one of the most common complications in both type 1 and type 2 diabetes mellitus. The most common symptom is a symmetrical, chronic, axonal, length-dependent sensorimotor polyneuropathy. Topical capsaicin formulations are widely used to manage pain. Low-concentration creams, lotions, and patches intended for daily skin application have been available in most countries since the early 1980s. We study 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial for 20 weeks throughout the study in 42 participants. All participants are provided both 0.075% capsaicin lotion and placebo lotion. Each agent will be applied for 8 weeks then stop for 4 weeks, after that another agent will be used for 8 weeks. We keep following up all of them by calling and appointment to get information in effectiveness and adverse effect at 0,2,4,8,12,14,16,20 week, respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.075% Capsaicin Lotion | To apply 3-4 times per day, every day until 8 weeks then stop |
| DRUG | placebo | To apply 3-4 times per day, every day until 8 weeks then stop |
Timeline
- Start date
- 2017-01-19
- Primary completion
- 2017-04-21
- Completion
- 2018-01-31
- First posted
- 2017-04-13
- Last updated
- 2018-09-12
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03113448. Inclusion in this directory is not an endorsement.